US Patent 12012449 Human IL-23 antigen binding proteins
Patent 12012449 was granted and assigned to Amgen on June, 2024 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 12012449 Human IL-23 antigen binding proteins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
